Medical research for Blood Cancers has proven to extend the lives of leukemia, lymphoma, and myeloma patients. Many patients are cured because of life saving medicine.
Prevalence is the estimated number of people alive on a certain date in a population who previously had a diagnosis of the disease. An estimated 1,185,053 people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma.
Relative survival compares the survival rate of a person diagnosed with a disease to that of a person without the disease. The most recent survival data available may not fully represent the outcomes of all current therapies and, as a result, may underestimate survival to a small degree.